Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease | Zendy

Bernard De Bruyne | Zendy; Nico H.J. Pijls | Zendy; Bindu Kalesan | Zendy; Emanuele Barbato | Zendy; Pim A.L. Tonino | Zendy; Zsolt Piróth | Zendy; Nikola Jagić | Zendy; Sven MöbiusWinkler | Zendy; Gilles Rioufol | Zendy; Nils Witt | Zendy; Petr Kala | Zendy; Philip MacCarthy | Zendy; Thomas Engström | Zendy; Keith G. Oldroyd | Zendy; Kreton Mavromatis | Zendy; Ganesh Manoharan | Zendy; Peter VerLee | Zendy; Ole Frøbert | Zendy; Nick Curzen | Zendy; Jane B. Johnson | Zendy; Peter Jüni | Zendy; William F. Fearon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Fractional Flow Reserve–Guided PCI versus Medical Therapy in Stable Coronary Disease

Author(s) -

Bernard De Bruyne,

Nico H.J. Pijls,

Bindu Kalesan,

Emanuele Barbato,

Pim A.L. Tonino,

Zsolt Piróth,

Nikola Jagić,

Sven MöbiusWinkler,

Gilles Rioufol,

Nils Witt,

Petr Kala,

Philip MacCarthy,

Thomas Engström,

Keith G. Oldroyd,

Kreton Mavromatis,

Ganesh Manoharan,

Peter VerLee,

Ole Frøbert,

Nick Curzen,

Jane B. Johnson,

Peter Jüni,

William F. Fearon

Publication year - 2012

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1205361

Subject(s) - fractional flow reserve , medicine , conventional pci , percutaneous coronary intervention , medical therapy , coronary artery disease , cardiology , coronary angiography , myocardial infarction

The preferred initial treatment for patients with stable coronary artery disease is the best available medical therapy. We hypothesized that in patients with functionally significant stenoses, as determined by measurement of fractional flow reserve (FFR), percutaneous coronary intervention (PCI) plus the best available medical therapy would be superior to the best available medical therapy alone.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research